Which markets have you exported to?

We have exported to over 80 countries, including regions in South America, Southeast Asia, the Middle East, and Africa.

Can you help with drug registration?

Yes, our professional team is responsible for registration and can provide necessary documents and samples.

High Quality Pharmaceutical Ampicillin Sodium for Injection 1.0g with GMP Certificate

Name: High Quality Pharmaceutical Ampicillin Sodium for Injection 1.0g with GMP Certificate
Brand: REYOUNG PHARMACEUTICAL CO., LTD.
SKU: 931828935

Shandong, ChinaREYOUNG PHARMACEUTICAL CO., LTD.

US$0.091

100,000 vial

Sample price:US$2.00/vial.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Lu20160062

Drug Ad Approval No.

Lu20160062

Certificate

GMP, ISO, SGS

Transport Package

10vials/Tray/Box, 50vials/Tray/Box.

Specification

1.0g

Trademark

Reyoung

Origin

China

HS Code

3003909090

Production Capacity

5millions

Key features

GMP & ISO Certified: Passed GMP, ISO9001, ISO14001, and OHS18001 international certifications.

Massive Production Capacity: Annual output of 2 billion injection vials, 10 billion tablets, and 1 billion capsules.

Global Market Presence: Exported to over 80 countries with successful MOH inspections in Africa and South America.

OEM/ODM Services: Accepts contract manufacturing and OEM services for custom pharmaceutical needs.

Professional Registration Support: Dedicated team provides necessary documents and samples for drug registration.

Extensive Export Experience: Over 35 years of export experience with a workforce of 5000 staff.

Comprehensive Product Range: Covers antibiotics, analgesics, vitamins, and cardiovascular drugs including APIs.

Flexible Payment Terms: Supports LC, T/T, and D/P payment methods for international trade.

Company profile

REYOUNG PHARMACEUTICAL CO., LTD.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤18h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.

Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.

CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.

Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.

Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What certifications does the product have?

The product has passed GMP, ISO9001, ISO14001, and OHS18001 international quality and management system certifications.

Q:What is the annual production capacity?

Annual capacity includes 2 billion injection vials, 500 million ampoules, 10 billion tablets, 1 billion capsules, 100 million granule bags, and 2000 tons of API.

Q:Do you accept OEM or custom orders?

Yes, we accept OEM, contract manufacturing, and ODM services for pharmaceutical products.

Q:What are the payment terms?

We accept LC, T/T, and D/P as terms of payment for international transactions.

Q:What is the lead time for production?

The average lead time is 1-3 months for both peak season and off-season periods.